BioCatalystWatch
VRDNWorkspace / VRDN / OverviewCompany library
Viridian Therapeutics, Inc.\\DE logo

Viridian Therapeutics, Inc.\DE

Viridian Therapeutics, Inc.\DE (VRDN)

Website

Price
Market cap
Next catalystExpected Q4 2026VRDN-292 — planned Phase 1 in Graves’ disease · Trial initiationCompany presentation ↗
Cash

Chart & Events

Candle interval

Core Clinical

Elegrobart

IGF-1R

PreINDP1P2P3FilingApproved
Upcoming / outlook

VRDN-292

TSHR

PreINDP2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

VRDN-292

TSHR

PreINDP2P3FilingApproved
Upcoming / outlook

Elegrobart

IGF-1R

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

Enspryng

IL-6R

PreINDP1P2P3FilingApproved
VRDN-008

FcRn × Albumin

VRDN-008

FcRn × Albumin

PreINDP1P2P3FilingApproved
Elegrobart

IGF-1R

PreINDP1P2P3FilingApproved
Upcoming / outlook

VRDN-006

FcRn

VRDN-006

FcRn

PreINDP1P2P3FilingApproved
Elegrobart

VRDN-008

FcRn × Albumin

Upcoming / outlook

IGF-1R

Approved / commercial

IGF-1R

Approved

PreINDP1P2P3FilingApproved

History / paused

miR-92/92a

PreINDP1P2P3FilingApproved

IGF-1R

PreINDP1P2P3FilingApproved

IGF-1R

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

VRDN PR & News

PR & News

VRDN SEC archive